Adult T-cell leukemia/lymphoma (ATL)

What is Adult T-cell leukemia/lymphoma (ATL)?

Adult T-cell leukemia/lymphoma is a rare and aggressive type of blood cancer. It affects white blood cells called T-cells that normally help your immune system fight infections. When these cells become cancerous, they multiply out of control and can spread throughout your body.

ATL is caused by a virus called human T-lymphotropic virus type 1, or HTLV-I. Most people who have HTLV-I infection will never develop ATL. Only about 2 to 5 out of every 100 people with the virus develop this cancer, usually after decades of infection. The condition is more common in Japan, the Caribbean, parts of Africa, and South America where HTLV-I infection rates are higher.

There are four main types of ATL based on how quickly it progresses. Acute and lymphoma types grow very fast and require urgent treatment. Chronic and smoldering types develop more slowly. Understanding which type you have helps doctors plan the right treatment approach.

Symptoms

Symptoms of ATL vary depending on the type and how advanced the disease is. Common signs include:

  • Swollen lymph nodes in the neck, armpits, or groin
  • Frequent infections that are hard to shake
  • Unexplained fever that comes and goes
  • Night sweats that soak your clothes or sheets
  • Extreme tiredness that does not improve with rest
  • Unintentional weight loss of 10 pounds or more
  • Skin rashes or lesions that may be itchy
  • Bone pain or fractures from weakened bones
  • Confusion or changes in mental function
  • High calcium levels causing nausea or excessive thirst

Some people with slower-growing types of ATL may have no symptoms for months or years. Others may only notice swollen lymph nodes at first. Any persistent or concerning symptoms should be discussed with a doctor right away.

Pay with HSA/FSA

Concerned about Adult T-cell leukemia/lymphoma (ATL)? Check your levels.

Screen for 1,200+ health conditions

Screen for 1,200+ health conditions
Hassle-free all-in-one body check
Testing 2 times a year and on-demand
Health insights from licensed doctors
Clear next steps for instant action
Track progress & monitor trends
Results explained in plain English
No insurance, no hidden fees

Causes and risk factors

ATL is caused by long-term infection with the HTLV-I virus. This virus spreads through blood, sexual contact, breastfeeding, or sharing needles. Most people get infected during childhood through breastfeeding from an infected mother. The virus can stay dormant in your body for 20 to 60 years before ATL develops, if it develops at all.

Risk factors for developing ATL include being infected with HTLV-I at a young age, having a family history of the infection, and living in areas where the virus is common. People of Japanese or Caribbean descent have higher infection rates. Men develop ATL slightly more often than women. Having a weakened immune system may also increase your risk of the virus becoming active and causing cancer.

How it's diagnosed

Diagnosing ATL requires several tests to confirm the presence of cancer and HTLV-I infection. Your doctor will start with a physical exam to check for swollen lymph nodes and an enlarged liver or spleen. Blood tests look for abnormal T-cells and check for HTLV-I DNA, which confirms infection with the virus. Additional blood work measures calcium levels, liver function, and how well your kidneys are working.

Your doctor may order a lymph node biopsy, where a small tissue sample is examined under a microscope. Imaging tests like CT scans or PET scans show how far the cancer has spread. Bone marrow biopsies help determine if cancer cells are present in your bone marrow. Talk to your doctor about which specialized tests are right for your situation and where to get them done.

Treatment options

Treatment for ATL depends on the type and how far the cancer has spread. Options include:

  • Chemotherapy using multiple drugs to kill cancer cells
  • Antiviral medications combined with immune system modulators
  • Stem cell transplant for eligible patients with aggressive types
  • Radiation therapy to shrink tumors in specific areas
  • Antibiotics to prevent and treat infections
  • Medications to lower high calcium levels
  • Clinical trials testing new targeted therapies
  • Supportive care to manage symptoms and improve quality of life
  • Regular monitoring for slower-growing smoldering or chronic types

Lifestyle changes can help support your body during treatment. Eat a nutrient-rich diet with plenty of protein to maintain strength. Stay as active as possible to preserve muscle mass and energy. Avoid contact with people who are sick to reduce infection risk. Work closely with an oncologist who specializes in blood cancers to create a treatment plan that fits your needs.

Frequently asked questions

ATL specifically affects T-cells and is always caused by HTLV-I virus infection. Other leukemias may affect different types of white blood cells and have various causes including genetic mutations or environmental exposures. ATL tends to be more aggressive than many other leukemias and requires specialized treatment approaches.

There is no proven way to prevent ATL if you are infected with HTLV-I. Most people with the virus never develop cancer. Regular monitoring with your doctor can help catch any changes early. Mothers with HTLV-I should not breastfeed to prevent passing the virus to their babies.

Survival depends heavily on which type of ATL you have. Aggressive acute and lymphoma types have an average survival of 6 to 10 months without treatment, longer with therapy. Chronic types may allow survival of 2 years or more. Smoldering ATL can remain stable for many years with monitoring.

ATL itself is not contagious. However, the HTLV-I virus that causes it can spread through blood, sexual contact, breastfeeding, or sharing needles. If you have HTLV-I, you should take precautions to prevent spreading the virus to others, such as using protection during sex and not sharing needles.

Early signs can include persistently swollen lymph nodes that do not hurt, unusual fatigue, or skin rashes. Some people notice frequent infections or unexplained fevers. Many people have no symptoms in early stages, especially with slower-growing types. Regular check-ups are important if you know you have HTLV-I infection.

Routine HTLV-I testing is not recommended for most people. Testing makes sense if you were born in or have family from high-risk areas like Japan, the Caribbean, or parts of Africa. You should also get tested if you have unexplained symptoms or are planning to donate blood or organs.

No diet or supplement can treat or cure ATL. However, good nutrition supports your body during cancer treatment. Eating enough protein helps maintain muscle mass. Staying hydrated and eating nutrient-dense foods can help manage side effects. Always check with your oncologist before taking any supplements during treatment.

Stem cell transplant offers the best chance for long-term survival in aggressive ATL. Studies show that up to 30 to 40 percent of patients achieve long-term remission after transplant. Success depends on many factors including your age, overall health, type of ATL, and whether cancer has spread widely.

Most doctors recommend yearly check-ups if you have HTLV-I infection but no signs of ATL. Your doctor will examine your lymph nodes and may order blood tests to check your white blood cell counts. Report any new symptoms like swollen lymph nodes, unexplained weight loss, or persistent fevers right away.

Researchers are testing several promising new approaches. Targeted therapies that attack specific proteins on cancer cells show potential. Immunotherapies that help your immune system fight cancer are in clinical trials. Combining antiviral drugs with chemotherapy has improved outcomes in some studies. Ask your oncologist about clinical trials you might qualify for.

Related medications